Quantcast
Last updated on April 20, 2014 at 5:20 EDT

Latest Women's Hospital Stories

2014-04-18 15:41:30

Researchers propose classification system revolutionizing communication of chromosomal abnormalities for research and clinical settings When talking about genetic abnormalities at the DNA level that occur when chromosomes swap, delete or add parts, there is an evolving communication gap both in the science and medical worlds, leading to inconsistencies in clinical and research reports. Now a study by researchers at Brigham and Women's Hospital (BWH) proposes a new classification system...

2014-04-10 09:55:23

Findings from the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, have revealed that adding the medication known as spironolactone (Aldactone) to existing therapy did not significantly reduce the composite time to either death from cardiovascular causes, surviving a cardiac arrest, or hospitaliization to manage heart failure in patients with heart failure and a preserved ejection fraction in a study funded by the National Heart, Lung and...

2014-03-05 12:27:31

LEARN Project will Track Cognitive Change in a Comparison Group of Older Individuals, and Initiate the First Tau Imaging Study in a Longitudinal Prevention Trial CHICAGO, March 5, 2014 /PRNewswire-USNewswire/ -- The Alzheimer's Association today announced its largest ever research grant - $8 million over four years - to support the Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) study as a companion study to the Anti-Amyloid Treatment in Asymptomatic Alzheimer's...

2014-02-24 08:28:05

Patient Recruitment and Enrollment Now Underway WOODCLIFF LAKE, N.J., Feb. 24, 2014 /PRNewswire/ -- Eisai Inc. today announced that patient recruitment and enrollment are currently underway for CAMELLIA-TIMI 61, a randomized double-blind, placebo-controlled outcomes trial to evaluate the effect of long-term treatment with lorcaserin HCl on the incidence of major adverse cardiovascular events and new onset type 2 diabetes mellitus in obese (BMI > 30 kg/m(2)) and overweight (BMI > 27...

2014-02-11 10:45:41

Researchers at Brigham and Women's Hospital (BWH) and Carnegie Mellon University have introduced a unique micro-robotic technique to assemble the components of complex materials, the foundation of tissue engineering and 3D printing. Described in the Jan. 28, 2014, issue of Nature Communications, the research was conducted by Savas Tasoglu, PhD, MS, research fellow in the BWH Division of Renal Medicine, and Utkan Demirci, PhD, MS, associate professor of Medicine in the Division of...

2014-02-03 16:24:54

CARLSBAD, Calif., Feb. 3, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that Joseph Loscalzo, M.D., Ph.D., has joined the company's Board of Directors. Dr. Loscalzo is head of the department of medicine and physician-in-chief at Brigham & Women's Hospital, Harvard Medical School. Dr. Loscalzo is recognized as a leading cardiologist focused on identifying the role of endothelial cells and platelets in atherosclerosis and thrombosis. (Logo:...

2014-01-13 08:30:21

Research confirms long-held industry standard for optimal medication adherence and finds moderate levels of adherence demonstrated no protective benefit WOONSOCKET, R.I., Jan. 13, 2014 /PRNewswire/ -- New research conducted by CVS Caremark (NYSE: CVS) and Brigham and Women's Hospital published in the January 2014 issue of the American Heart Journal, validates the effectiveness of a widely-used standard for optimal medication adherence. The study confirmed that patients need to...

Bio-inspired Glue May Improve How Surgeons Treat Congenital Heart Defects And Other Heart Problems
2014-01-09 10:43:36

Brigham and Women's Hospital When a child is born with a heart defect such as a hole in the heart, the highly invasive therapies are challenging due to an inability to quickly and safely secure devices inside the heart. Sutures take too much time to stitch and can cause stress on fragile heart tissue, and currently available clinical adhesives are either too toxic or tend to lose their sticking power in the presence of blood or under dynamic conditions, such as in a beating heart....

2014-01-09 04:20:41

PARIS, January 9, 2014 /PRNewswire/ -- Innovative adhesive technology published as a cover feature in the high impact journal, Science Translational Medicine Gecko Biomedical, a French medical device company developing 'bio-inspired' biodegradable surgical glues and patches for wound closure, announces that the Company's co-founders have published data demonstrating the potential of its paradigm-shifting technologies for minimally invasive...

Nanomedicine May One Day Be Delivered Orally
2013-11-28 04:43:35

redOrbit Staff & Wire Reports - Your Universe Online Researchers from MIT and Brigham and Women's Hospital (BWH) have developed a new type of nanoparticle that can be absorbed through the digestive tract, bringing the cutting-edge treatment method one-step closer to being administered orally instead of through injections. While drugs delivered by nanoparticles could help treat cancer, diabetes and several other types of disease, the fact that these particles currently have to be...